A multipronged team of researchers, including C3.ai DTI researcher Ziv Bar-Joseph of Carnegie Mellon University, discovered at least 18 existing, FDA-approved drugs that could potentially be repurposed to combat COVID-19 infections shortly after a person becomes infected. Experimentally, five of those drugs reduced coronavirus spread in human lung cells by more than 90 percent. Their findings were published in Molecular Cell.

Read more here.